$2.5 Million Gift Goes to UC Psychiatry Department
A $2 million portion of the gift will establish the Dr. Stanley and Mickey Kaplan Endowed Chair in Psychiatry.
The Kaplan Chair will be awarded to the chairman of the department of psychiatry.
This gift will continue Dr. Kaplans great legacy in our department, said Stephen Strakowski, MD, interim chair of the psychiatry department. His generosity exceeds our simple words of thanks, but is greatly appreciated as further indication of Dr. Kaplans strong commitment to our department and the field of mental health.
The field of psychiatry is ever-changing, and this gift will be instrumental in helping us nurture all that is best in our existing traditions and in future therapeutic developments, said David Stern, MD, dean of the
Stanley Kaplan, MD, is an alumnus of the
Kaplan went on to become full professor and at one time was interim chairman of the psychiatry department. He has served on nearly every
In 1991 he established the national Stanley M. Kaplan Essay Contest to encourage improved writing and research skills among medical students.
During his career at UC, Kaplan was involved not only in service and teaching, but also in research. He is published widely for his work on a range of topics in psychiatryparticularly for studies in psychosomatic medicine.
Now an emeritus professor, Kaplan is on campus almost every day and continues to do some psychotherapy and teaching.
I am proud to be part of what was and still is one of the finest departments of psychiatry in the country, said Kaplan. I was fortunate to serve on the faculty of one of the first psychiatry departments that encouraged interest not only in psychiatry, but also the arts and humanities, he added.
A strong supporter of the arts, Kaplanthrough the Dr. Stanley and Mickey Kaplan Foundationin 2003 established the Kaplan Prize in honor of his late wife Mickey Jarson Kaplan. The prize is awarded annually to support the production of a new play at the Playhouse in the Park in
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.